![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
01 Adalimumab (1)
02 Aflibercept (1)
03 Alemtuzumab (1)
04 Alirocumab (1)
05 Atezolizumab (1)
06 Bevacizumab (1)
07 Cetuximab (1)
08 Daratumumab (1)
09 Denosumab (1)
10 Dulaglutide (1)
11 Eculizumab (1)
12 Evolocumab (1)
13 Infliximab (1)
14 Ipilimumab (1)
15 Mepolizumab (1)
16 Natalizumab (1)
17 Nivolumab (1)
18 Omalizumab (1)
19 Panitumumab (1)
20 Pembrolizumab (1)
21 Pertuzumab (1)
22 Ramucirumab (1)
23 Rituximab (1)
24 Secukinumab (1)
25 Tocilizumab (1)
26 Trastuzumab (1)
27 Ustekinumab (1)
28 Vedolizumab (1)
01 Blank (28)
01 Blank (28)
01 Blank (28)
01 Blank (28)
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC
USDMF
CEP/COS
JDMF
WC